Literature DB >> 23917443

The retinal nerve fiber layer of patients with neuromyelitis optica and chronic relapsing optic neuritis is more severely damaged than patients with multiple sclerosis.

Denis B Bichuetti1, André S de Camargo, Alessandra B Falcão, Fabiana F Gonçalves, Ivan M Tavares, Enedina M L de Oliveira.   

Abstract

BACKGROUND: To compare the retinal nerve fiber layer (RNFL) in eyes of patients with relapsing remitting multiple sclerosis (RRMS), neuromyelitis optica (NMO) and chronic relapsing inflammatory optic neuritis (CRION).
METHODS: Evaluation of 62 patients with RRMS, NMO, and CRION in a cross-sectional study with spectral domain optical coherence tomography.
RESULTS: A total of 124 eyes were evaluated (96 RRMS, 18 NMO, and 10 CRION). Frequency of optic neuritis for each disease was: 34% for RRMS, 84% for NMO, and 100% for CRION. Visual acuity and RNFL thickness were significantly worse in NMO and CRION eyes than in RRMS, but there were no differences between NMO and CRION eyes. A RNFL of 41 μm was 100% specific for optic neuritis associated with NMO and CRION when compared to RRMS.
CONCLUSION: This study established RNFL values to differentiate optic neuritis of RRMS from NMO and CRION. Although similarities observed between NMO and CRION eyes might suggest that they are within the same disease spectrum, it is still recommended that these 2 conditions be differentiated on clinical grounds. Optical coherence tomography serves as an additional diagnostic tool and can be used to monitor disease progression.

Entities:  

Mesh:

Year:  2013        PMID: 23917443     DOI: 10.1097/WNO.0b013e31829f39f1

Source DB:  PubMed          Journal:  J Neuroophthalmol        ISSN: 1070-8022            Impact factor:   3.042


  8 in total

Review 1.  The investigation of acute optic neuritis: a review and proposed protocol.

Authors:  Axel Petzold; Mike P Wattjes; Fiona Costello; Jose Flores-Rivera; Clare L Fraser; Kazuo Fujihara; Jacqueline Leavitt; Romain Marignier; Friedemann Paul; Sven Schippling; Christian Sindic; Pablo Villoslada; Brian Weinshenker; Gordon T Plant
Journal:  Nat Rev Neurol       Date:  2014-07-08       Impact factor: 42.937

Review 2.  The Contribution of Optical Coherence Tomography in Neuromyelitis Optica Spectrum Disorders.

Authors:  Javier Mateo; Olivia Esteban; Mireya Martínez; Andrzej Grzybowski; Francisco Javier Ascaso
Journal:  Front Neurol       Date:  2017-09-29       Impact factor: 4.003

3.  Impact of the anti-aquaporin-4 autoantibody on inner retinal structure, function and structure-function associations in Japanese patients with optic neuritis.

Authors:  Yoshiko Matsumoto; Sotaro Mori; Kaori Ueda; Takuji Kurimoto; Akiyasu Kanamori; Yuko Yamada; Ichiro Nakashima; Makoto Nakamura
Journal:  PLoS One       Date:  2017-02-15       Impact factor: 3.240

Review 4.  Optic neuritis as an early sign of multiple sclerosis.

Authors:  Nilufer Kale
Journal:  Eye Brain       Date:  2016-10-26

5.  Retinal Degeneration After First-Ever Optic Neuritis Helps Differentiate Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder.

Authors:  Nam-Hee Kim; Ho Jin Kim; Cheol-Yong Park; Kyoung Sook Jeong
Journal:  Front Neurol       Date:  2019-10-10       Impact factor: 4.003

6.  Effect of Obesity on Retinal Integrity in African Americans and Caucasian Americans With Relapsing Multiple Sclerosis.

Authors:  Jacob Rube; Madeline Bross; Christopher Bernitsas; Melody Hackett; Fen Bao; Evanthia Bernitsas
Journal:  Front Neurol       Date:  2021-11-24       Impact factor: 4.003

7.  Evaluation of Retinal Nerve Fiber Layer and Ganglion Cell Complex in Patients with Optic Neuritis or Neuromyelitis Optica Spectrum Disorders Using Optical Coherence Tomography in a Chinese Cohort.

Authors:  Guohong Tian; Zhenxin Li; Guixian Zhao; Chaoyi Feng; Mengwei Li; Yongheng Huang; Xinghuai Sun
Journal:  J Ophthalmol       Date:  2015-11-15       Impact factor: 1.909

Review 8.  Update on the diagnosis and treatment of neuromyelitis optica: recommendations of the Neuromyelitis Optica Study Group (NEMOS).

Authors:  Corinna Trebst; Sven Jarius; Achim Berthele; Friedemann Paul; Sven Schippling; Brigitte Wildemann; Nadja Borisow; Ingo Kleiter; Orhan Aktas; Tania Kümpfel
Journal:  J Neurol       Date:  2013-11-23       Impact factor: 4.849

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.